Met Life Investment Management, LLC Uro Gen Pharma Ltd. Transaction History

Met Life Investment Management, LLC

$16.5 Billion
Q2 2025

A detailed history of Met Life Investment Management, LLC transactions in Uro Gen Pharma Ltd. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 22,766 shares of URGN stock, worth $410,698. This represents 0.0% of its overall portfolio holdings.

Number of Shares

22,766

Previous 22,766 -0.0%

Holding current value

$410,698

Previous $251,000 23.9%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$10.52 - $13.11 $28,688 - $35,750	2,727 Added 13.61%	22,766 $242,000
Q2 2024 Aug 13, 2024	BUY	$12.72 - $19.2 $68,853 - $103,929	5,413 Added 37.01%	20,039 $336,000
Q1 2024 May 14, 2024	BUY	$13.81 - $19.33 $201,985 - $282,720	14,626 New	14,626 $219,000
Q4 2023 Feb 14, 2024	BUY	$10.87 - $15.93 $45,904 - $67,272	4,223 Added 40.59%	14,626 $219,000
Q3 2023 May 09, 2024	BUY	$8.84 - $22.64 $91,962 - $235,523	10,403 New	10,403 $145,000
Q2 2023 Apr 29, 2024	BUY	$8.75 - $14.29 $91,026 - $148,658	10,403 New	10,403 $107,000
Q2 2023 Aug 10, 2023	BUY	$8.75 - $14.29 $91,026 - $148,658	10,403 New	10,403 $107,000
Q3 2021 May 17, 2024	SELL	$14.31 - $18.39 $18,603 - $23,907	-1,300 Reduced 15.02%	7,354 $123,000
Q3 2021 Jun 21, 2023	BUY	$14.31 - $18.39 $105,235 - $135,240	7,354 New	7,354 $124 Million
Q1 2021 May 17, 2024	SELL	$17.99 - $26.96 $107,436 - $161,005	-5,972 Reduced 40.83%	8,654 $168,000
Q1 2021 Jun 26, 2023	BUY	$17.99 - $26.96 $155,685 - $233,311	8,654 New	8,654 $169 Million
Q4 2020 Jun 22, 2023	BUY	$17.54 - $25.43 $175,224 - $254,045	9,990 New	9,990 $180 Million
Q3 2020 Jun 26, 2023	BUY	$18.81 - $26.42 $187,911 - $263,935	9,990 New	9,990 $193 Million
Q2 2020 May 24, 2024	SELL	$16.5 - $29.7 $76,494 - $137,689	-4,636 Reduced 31.7%	9,990 $261 Million
Q2 2020 Jun 26, 2023	BUY	$16.5 - $29.7 $164,835 - $296,703	9,990 New	9,990 $261 Million
Q1 2020 Jul 12, 2023	BUY	$13.68 - $34.6 $136,663 - $345,654	9,990 New	9,990 $178 Million
Q4 2019 Jul 12, 2023	BUY	$21.11 - $34.86 $210,888 - $348,251	9,990 New	9,990 $333 Million
Q3 2019 Jul 12, 2023	BUY	$23.83 - $36.44 $238,061 - $364,035	9,990 New	9,990 $238 Million

Others Institutions Holding URGN

# of Institutions

163

Shares Held

39.6M

Call Options Held

2.06M

Put Options Held

717K

View Full List

About UroGen Pharma Ltd.

Ticker URGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 22,740,500
Market Cap $410M
Description
UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...

More about URGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Account

Met Life Investment Management, LLC Uro Gen Pharma Ltd. Transaction History